Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fruquintinib”

173 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 173 results

Testing effectiveness (Phase 2)Looking for participantsNCT06856837
What this trial is testing

- IKF/AIO-QUINTIS - Evaluating Fruquintinib in Combination With Tislelizumab in Microsatellite Stable / Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Cancer Without Active Liver Metastases

Who this might be right for
Metastatic Colorectal Cancer
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 140
Not applicableNot Yet RecruitingNCT07552402
What this trial is testing

Oral Paclitaxel Plus Fruquintinib Verus Investigator's Choice in Second-Line Advanced Gastric Cancer

Who this might be right for
Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
Harbin Medical University 150
Testing effectiveness (Phase 2)UnknownNCT04582981
What this trial is testing

Fruquintinib and Raltitrexed Versus Fruquintinib Monotherapy in Advanced Colorectal Cancer

Who this might be right for
Advanced Colorectal Carcinoma
Fudan University 136
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06888037
What this trial is testing

Fruquintinib Combined With PD-1 Inhibitor as First-line Maintenance Therapy for Advanced Gastric Cancer

Who this might be right for
Gastric AdenocarcinomaGEJ AdenocarcinomaFirst-line Therapy+3 more
Ruijin Hospital 55
Testing effectiveness (Phase 2)Looking for participantsNCT06148402
What this trial is testing

Fruquintinib Plus Camrelizumab and Capecitabine as Salvage Therapy After Progression on FOLFOXIRI-based First-line Treatment in Patients With Unresectable/Metastatic Colorectal Cancer

Who this might be right for
Unresectable/Metastatic Colorectal Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 30
Testing effectiveness (Phase 2)UnknownNCT04866862
What this trial is testing

Fruquitinib Combined With Camrelizumab in Non MSI-H/dMMR Refractory Colorectal Cancer

Who this might be right for
Colorectal Neoplasm
The First Affiliated Hospital with Nanjing Medical University 32
Early research (Phase 1)Study completedNCT04557397
What this trial is testing

Fruquintinib CYP3A Inhibitor and Inducer Study

Who this might be right for
Drug Drug Interaction
Hutchison Medipharma Limited 28
Not applicableLooking for participantsNCT06102759
What this trial is testing

Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin Paclitaxel for Advanced Gastric Cancer After PD-1 Antibody Failed

Who this might be right for
Gastric Cancer
Tianjin Medical University Cancer Institute and Hospital 30
Large-scale testing (Phase 3)Looking for participantsNCT07270991
What this trial is testing

Trifluridine/Tipiracil + Fruquintinib Versus Trifluridine/Tipiracil Alone for Metastatic Oeso-gastric Adenocarcinoma

Who this might be right for
Metastatic Oesogastric Adenocarcinoma
Federation Francophone de Cancerologie Digestive 324
Testing effectiveness (Phase 2)UnknownNCT05636150
What this trial is testing

A Phase II Clinical Study of Fruquintinib Combined With S-1 for Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Peking Union Medical College Hospital 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06218888
What this trial is testing

A Phase II Clinical Study of the Efficacy and Safety of Tislelizumab Combined With Fruquintinib and Chidamide in the Treatment of Unresectable or Advanced Microsatellite Stabilized (MSS/pMMR) Colorectal Cancer With Liver Metastases

Who this might be right for
Colo-rectal Cancer
Fujian Cancer Hospital 17
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06706895
What this trial is testing

A Single-arm, Single-center Phase II Clinical Study on the Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection Combined With Fruquintinib Capsules in the Second-line Treatment of Patients With Advanced Gastric Cancer

Who this might be right for
Advanced Gastric CancerPaclitaxel Polymeric Micelles for InjectionFruquintinib Capsules
Shanghai Zhongshan Hospital 21
Not applicableLooking for participantsNCT06102785
What this trial is testing

Fruquintinib Combined With TAS102 for Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07622550
What this trial is testing

A Single-arm, Multicenter Clinical Study of Fruquintinib Combined With Serplulimab and Chemotherapy as First-line Treatment for Patients With RAS/BRAF-mutated Advanced Colorectal Cance

Who this might be right for
Metastatic Colorectal Cancer (CRC)
Jiangsu Cancer Institute & Hospital 80
Not applicableNot Yet RecruitingNCT06470178
What this trial is testing

A Real-World Study of Neoadjuvant/Conversion Therapy for Colorectal Cancer With Chemotherapy And Anti-Angiogenic Targeted Agents

Who this might be right for
Colorectal Cancer
Wuhan University 70
Not applicableLooking for participantsNCT06551207
What this trial is testing

Cadonilimab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With MSS CRC

Who this might be right for
Metastatic Colorectal Cancer
Liu Huang 80
Large-scale testing (Phase 3)Looking for participantsNCT06441565
What this trial is testing

Fruquintinib With or Without HAI-FOLFOX for Refractory Colorectal Cancer

Who this might be right for
Colorectal Cancer
Sun Yat-sen University 84
Testing effectiveness (Phase 2)UnknownNCT06010888
What this trial is testing

Fruquintinib With mFOLFOX6/FOLFIRI as First-Line Therapy for Conversion Surgery in mCRC

Who this might be right for
Colorectal Cancer
Fudan University 92
Testing effectiveness (Phase 2)UnknownNCT06427005
What this trial is testing

Fruquintinib Plus S-1 and Raltitrexed (RSF) for MCRC

Who this might be right for
FruquintinibS-1Raltitrexed
Meng Qiu 66
Not applicableStudy completedNCT06202599
What this trial is testing

Fruquintinib-based Treatment for Refractory Bone and Soft Tissue Sarcomas After Several Lines of TKIs' Resistance

Who this might be right for
Bone SarcomaSoft Tissue SarcomaRefractory Tumor
Peking University People's Hospital 124
Load More Results